Total (US$) | Average cost profile (%) | Average cost per person treated per round (US$) | Average cost per capita per round (US$) | |||
MDA round | 1 | 2 | 1+2 | 1+2 | 1+2 | 1+2 |
Total | 60 320 | 54 305 | 114 626 | 100.0 | 1.14 | 0.84 |
Total incremental† | 4829 | 6577 | 11 406 | 10.0 | 0.11 | 0.08 |
Start-up activities‡ | 1094 | 1055 | 2149 | 1.9 | 0.02 | 0.02 |
Programme management | 21 300 | 20 540 | 41 840 | 36.5 | 0.42 | 0.31 |
Drug testing and distribution to site | 304 | 331 | 636 | 0.6 | 0.01 | 0.00 |
CDD recruitment | 1066 | 1028 | 2095 | 1.8 | 0.02 | 0.02 |
Community sensitisation | 12 924 | 9343 | 22 267 | 19.4 | 0.22 | 0.16 |
CDD bags and job aids | 555 | 428 | 983 | 0.9 | 0.01 | 0.01 |
Banners, posters | 969 | 969 | 1937 | 1.7 | 0.02 | 0.01 |
Training | 5003 | 2840 | 7843 | 6.8 | 0.08 | 0.06 |
Travel allowance for CDDs | 240 | 170 | 409 | 0.4 | 0.00 | 0.00 |
Refreshments for CDDs | 10 | 17 | 26 | 0.0 | 0.00 | 0.00 |
cMDA | 13 442 | 14 659 | 28 101 | 24.5 | 0.28 | 0.21 |
CDD incentives | 2632 | 4577 | 7210 | 6.3 | 0.07 | 0.05 |
CDD mobile allowance | 120 | 85 | 205 | 0.2 | 0.00 | 0.00 |
Coverage survey | 3116 | 2451 | 5567 | 4.9 | 0.06 | 0.04 |
Mop-up | 2070 | 2058 | 4128 | 3.6 | 0.04 | 0.03 |
Grey shaded rows are a subset of the higher level activity grouping. Total number of people treated in first round of cMDA (cMDA1) was 51 320 (site total population 68 442); in second round (cMDA2)—49 488 (site total population 68 460); total treated over the two rounds (cMDA1 +cMDA2) was 100 808 (total population 136 902). Costs were converted to USD using average annual exchange rate over the study period (1 INR=US$0.01462).34
*cMDA was implemented as a mop-up following NDD campaign that targeted school-aged children.
†Incremental costs represent a subset of rows highlighted in italics, see text for details.
‡Start-up activities annualised over the duration of the trial (5 years).
CDD, community drug distributor; cMDA, community-wide mass drug administration; STH, soil-transmitted helminth infections.